A Novel Peptide Derived from Human Apolipoprotein E Is an Inhibitor of Tumor Growth and Ocular Angiogenesis
Partha S. Bhattacharjee(National Oceanic and Atmospheric Administration), James M. Hill(University of Oxford), Harris E. McFerrin(Xavier University of Louisiana), Tashfin S. Huq(Xavier University of Louisiana), Tarun K. Mandal(Vidyasagar University), Christian Clément(Ophthalmology Associates (United States)), Richard A Graves(Xavier University of Louisiana), Syed Muniruzzaman(Xavier University of Louisiana)
Cited by 32
Related Papers
Current and Emerging Developments in Subseasonal to Decadal Prediction
|Bulletin of the American Meteorological Society|2020|311
Current state of the global operational aerosol multi‐model ensemble: An update from the International Cooperative for Aerosol Prediction (ICAP)
|Quarterly Journal of the Royal Meteorological Society|2019|153
Ocular HSV-1 Latency, Reactivation and Recurrent Disease
|Seminars in Ophthalmology|2008|142
Ocular Herpes Simplex Virus: How are Latency, Reactivation, Recurrent Disease and Therapy Interrelated?
|Future Microbiology|2011|116
Drug delivery to the posterior segment of the eye for pharmacologic therapy
|Expert Review of Ophthalmology|2010|99